Download Files:
SKI V
SKU
HY-12895-10 mg
Category Reference compound
Tags Apoptosis;Immunology/Inflammation;PI3K/Akt/mTOR, Apoptosis;PI3K;SphK, Cancer
$280 – $1,850
Products Details
Product Description
– SKI V is a noncompetitive and potent non-lipid sphingosine kinase (SPHK; SK) inhibitor with an IC50 of 2 μM for GST-hSK. SKI V potently inhibits PI3K with an IC50 of 6 μM for hPI3k. SKI V decreases formation of the mitogenic second messenger sphingosine-1-phosphate (S1P). SKI V induces apoptosis and has antitumor activity[1][2].
Web ID
– HY-12895
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C15H10O4
References
– [1]French KJ, et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 2003 Sep 15;63(18):5962-9.|[2]French KJ, et al. Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther. 2006 Aug;318(2):596-603.
CAS Number
– 24418-86-8
Molecular Weight
– 254.24
Compound Purity
– 98.09
SMILES
– O=C1/C(OC2=CC=CC=C12)=C/C3=CC=C(O)C(O)=C3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 50 mg/mL (ultrasonic)
Target
– Apoptosis;PI3K;SphK
Pathway
– Apoptosis;Immunology/Inflammation;PI3K/Akt/mTOR
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.